|
Pfizer returns asthma drug development to Rigel
Ventura County Star (AP) – Rigel Pharmaceuticals Inc. said Friday it will take over development from Pfizer Inc. of a potential allergic asthma treatment that recently completed several early-stage clinical trials. The South San Francisco, Calif., development-stage … Rigel Assumes Development Responsibility For Inhaled Asthma Losing Biobucks as Pharma Reshuffles Its Deck Pfizer returns asthma drug candidate rights to Rigel Pharma; latter narrows losses |
View full post on asthma – Google News